AR228957A1 - Procedimiento para obtener compuestos del acido 1-bencil-4-halo-imidazol-5-acetico y de sus sales y procedimiento para preparar composiciones farmaceuticas que incluyen a dichos compuestos del acido 1-bencil-4-haloimidazol-5-acetico,como agente activo - Google Patents

Procedimiento para obtener compuestos del acido 1-bencil-4-halo-imidazol-5-acetico y de sus sales y procedimiento para preparar composiciones farmaceuticas que incluyen a dichos compuestos del acido 1-bencil-4-haloimidazol-5-acetico,como agente activo

Info

Publication number
AR228957A1
AR228957A1 AR283170A AR28317080A AR228957A1 AR 228957 A1 AR228957 A1 AR 228957A1 AR 283170 A AR283170 A AR 283170A AR 28317080 A AR28317080 A AR 28317080A AR 228957 A1 AR228957 A1 AR 228957A1
Authority
AR
Argentina
Prior art keywords
bencil
procedure
compounds
haloimidazole
imidazol
Prior art date
Application number
AR283170A
Other languages
English (en)
Spanish (es)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of AR228957A1 publication Critical patent/AR228957A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR283170A 1979-11-12 1980-11-10 Procedimiento para obtener compuestos del acido 1-bencil-4-halo-imidazol-5-acetico y de sus sales y procedimiento para preparar composiciones farmaceuticas que incluyen a dichos compuestos del acido 1-bencil-4-haloimidazol-5-acetico,como agente activo AR228957A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14672879A JPS5671074A (en) 1979-11-12 1979-11-12 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative

Publications (1)

Publication Number Publication Date
AR228957A1 true AR228957A1 (es) 1983-05-13

Family

ID=15414223

Family Applications (1)

Application Number Title Priority Date Filing Date
AR283170A AR228957A1 (es) 1979-11-12 1980-11-10 Procedimiento para obtener compuestos del acido 1-bencil-4-halo-imidazol-5-acetico y de sus sales y procedimiento para preparar composiciones farmaceuticas que incluyen a dichos compuestos del acido 1-bencil-4-haloimidazol-5-acetico,como agente activo

Country Status (19)

Country Link
US (1) US4355040A (sv)
EP (1) EP0028834B1 (sv)
JP (1) JPS5671074A (sv)
AR (1) AR228957A1 (sv)
AT (1) ATE5880T1 (sv)
AU (1) AU6412280A (sv)
CA (1) CA1152516A (sv)
DE (1) DE3066205D1 (sv)
DK (1) DK478980A (sv)
ES (1) ES496709A0 (sv)
FI (1) FI803508L (sv)
GR (1) GR72124B (sv)
HU (1) HU185389B (sv)
IL (1) IL61359A0 (sv)
NO (1) NO151966C (sv)
NZ (1) NZ195517A (sv)
PT (1) PT72049B (sv)
SU (1) SU999966A3 (sv)
ZA (1) ZA806832B (sv)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181082A (en) * 1981-11-20 1985-01-15 Toni Dockner Substituted benzylimidazolium salts and microbicides containing these compounds
JPS58157768A (ja) * 1982-03-16 1983-09-19 Takeda Chem Ind Ltd 4−クロロ−2−フエニルイミダゾ−ル−5−酢酸誘導体
ATE25521T1 (de) * 1982-12-20 1987-03-15 Merck & Co Inc 5-(amino oder substituierte amino)-imidazole.
US4602093A (en) * 1984-02-08 1986-07-22 Merck & Co., Inc. Novel substituted imidazoles, their preparation and use
US5036048A (en) * 1986-03-07 1991-07-30 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
US5182264A (en) * 1986-03-07 1993-01-26 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
NZ221427A (en) * 1986-08-18 1990-12-21 Smithkline Beckman Corp 2-mercaptoimidazole derivatives and pharmaceutical compositions
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5081127A (en) * 1988-01-07 1992-01-14 E. I. Du Pont De Nemours And Company Substituted 1,2,3-triazole angiotensin II antagonists
US5189048A (en) * 1988-01-07 1993-02-23 E. I. Du Pont De Nemours And Company Substituted 1,2,3 triazole angiotensin II antagonists
US5315013A (en) * 1988-01-07 1994-05-24 E. I. Du Pont De Nemours And Company Substituted pyrazole angiotensin II antagonists
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5210079A (en) * 1988-01-07 1993-05-11 E. I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
EP0733366B1 (en) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
JPH029507A (ja) * 1988-06-24 1990-01-12 Teikku Ag 迅速交換形タップホルダ
US5354867A (en) * 1988-12-06 1994-10-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
ATE190051T1 (de) * 1989-06-14 2000-03-15 Smithkline Beecham Corp Imidazoalkensäure
US5312828A (en) * 1989-06-14 1994-05-17 Finkelstein Joseph A Substituted imidazoles having angiotensin II receptor blocking activity
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
JP2568315B2 (ja) * 1989-06-30 1997-01-08 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 縮合環アリール置換イミダゾール
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
DE69013607T2 (de) * 1989-08-02 1995-03-02 Takeda Chemical Industries Ltd Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5177096A (en) * 1989-10-25 1993-01-05 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical methods of use thereof
US5248689A (en) * 1989-11-06 1993-09-28 Smithkline Beecham Corporation Substituted N-(imidazolyl)alkyl alanine derivatives
CA2028925A1 (en) * 1989-11-06 1991-05-07 Gerald R. Girard Substituted n-(imidazolyl)alkyl alanine derivatives
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
EP0557276A1 (en) * 1989-12-29 1993-09-01 University Technologies International Inc. (Uti) Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
US5234917A (en) * 1989-12-29 1993-08-10 Finkelstein Joseph A Substituted 5-(alkyl)carboxamide imidazoles
JPH05503691A (ja) * 1989-12-29 1993-06-17 ユニバーシティ・テクノロジーズ・インターナショナル・インコーポレイテッド アゴニストおよびアンタゴニストを含む生物学的に活性なリガンドの3次構造モデルの設計方法およびアンギオテンシンに基づいた新規合成アンタゴニスト
JPH0396182U (sv) * 1990-01-19 1991-10-01
US5011851A (en) * 1990-02-13 1991-04-30 Bristol-Myers Squibb Co. Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
EP0442448A3 (en) 1990-02-13 1992-08-12 Bristol-Myers Squibb Company Heterocyclic carboxylic acids and esters
US5162326A (en) * 1990-02-15 1992-11-10 Takeda Chemical Industries, Ltd. Pyrimidinedione derivatives, their production and use
EP0443983B1 (de) * 1990-02-19 1996-02-28 Ciba-Geigy Ag Acylverbindungen
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
FR2665702B1 (fr) * 1990-08-08 1994-02-25 Sanofi Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US6004989A (en) * 1990-04-27 1999-12-21 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
ZA912983B (en) 1990-04-27 1992-01-29 Takeda Chemical Industries Ltd Benzimidazole derivatives,their production and use
US5703110A (en) * 1990-04-27 1997-12-30 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
KR970005839B1 (ko) 1990-05-11 1997-04-21 화이자 인코포레이티드 상승 치료효과를 얻기 위한 조성물 및 방법
US5821232A (en) * 1990-05-11 1998-10-13 Pfizer Inc. Synergistic therapeutic compositions and methods
NZ238688A (en) * 1990-06-28 1992-05-26 Smithkline Beecham Corp Substituted histidines: pharmaceutical compositions, preparation and uses thereof
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
US5374615A (en) * 1990-10-31 1994-12-20 E. R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
DE4036706A1 (de) * 1990-11-17 1992-05-21 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
CA2058198A1 (en) * 1991-01-04 1992-07-05 Adalbert Wagner Azole derivatives, process for their preparation, and their use
TW197428B (sv) 1991-01-04 1993-01-01 Hoechst Ag
US5153347A (en) * 1991-01-31 1992-10-06 E. R. Squibb & Sons, Inc. Phosphonate, phosphinate derivatives useful as antihypertensive agents
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
US5104877A (en) * 1991-02-25 1992-04-14 Abbott Laboratories Psoriasis treatment
US5191086A (en) * 1991-03-19 1993-03-02 E.R. Squibb & Sons, Inc. Imidazole and benzimidazole derivatives
US5177074A (en) 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
TW274551B (sv) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
US5190942A (en) * 1991-04-22 1993-03-02 E. R. Squibb & Sons, Inc. Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
GB9110635D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
GB9110636D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
US5332820A (en) * 1991-05-20 1994-07-26 E. I. Du Pont De Nemours And Company Dibenzobicyclo(2.2.2) octane angiotensin II antagonists
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
US5177097A (en) * 1991-07-24 1993-01-05 E. R. Squibb & Sons, Inc. Acyl amidine and acyl, guanidine substituted biphenyl derivatives
US5322950A (en) * 1991-12-05 1994-06-21 Warner-Lambert Company Imidazole with angiotensin II antagonist properties
US5389661A (en) * 1991-12-05 1995-02-14 Warner-Lambert Company Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
US5212177A (en) * 1991-12-16 1993-05-18 E. R. Squibb & Sons, Inc. Indole and benzimidazole-substituted dihydropyrimidine derivatives
TW215434B (sv) * 1992-03-07 1993-11-01 Hoechst Ag
US5208234A (en) * 1992-03-10 1993-05-04 E. R. Squibb & Sons, Inc. Substituted imidazole phosphonic and phosphinic acid derivatives
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
US5616591A (en) * 1992-03-27 1997-04-01 E.R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted quinoline derivatives
US5294722A (en) * 1992-04-16 1994-03-15 E. R. Squibb & Sons, Inc. Process for the preparation of imidazoles useful in angiotensin II antagonism
DE4212796A1 (de) * 1992-04-16 1993-10-21 Bayer Ag Propenoyl-imidazolderivate
US5380719A (en) * 1992-04-28 1995-01-10 E. R. Squibb & Sons, Inc. Quinoxaline biphenyl angiotensin II inhibitors
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
DE4221009A1 (de) * 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituierte Cyclohexanderivate
DE4220983A1 (de) * 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituierte Phenylpropion- und -zimtsäurederivate
RU2103262C1 (ru) * 1992-07-16 1998-01-27 Лонца АГ Гампель/Валлис Способ получения 2-замещенных 5-хлоримидазол-4-карбальдегидов
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
TW240224B (sv) * 1993-02-15 1995-02-11 Shikoku Kakoki Co Ltd
US5484939A (en) * 1993-03-12 1996-01-16 Lonza Ltd. 2-substituted 5-chlorimidazoles
EP0614889A1 (de) * 1993-03-12 1994-09-14 Lonza Ag Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlorimidazol-4-carbaldehyden
DK0614890T3 (da) * 1993-03-12 1997-10-13 Lonza Ag Fremgangsmåde til fremstilling af eventuelt 2-substituerede 5-chlorimidazoler.
US5442075A (en) * 1993-03-12 1995-08-15 Lonza Ltd. Process for the production of 2-substituted 5-chlorimidazole-4-carbaldehydes
AU679735B2 (en) * 1993-04-07 1997-07-10 Nissan Chemical Industries Ltd. Pyrazole derivative
CA2135541C (en) * 1993-11-15 2006-01-10 Gareth Griffiths Process for the preparation of 2-substituted 5-chloroimidazole-4-carbaldehydes
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AU690270B2 (en) * 1994-05-20 1998-04-23 Smithkline Beecham Corporation Intermediate for preparing a pharmaceutically active compound
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
ES2136782T3 (es) 1994-10-27 1999-12-01 Asahi Glass Co Ltd Procedimiento para producir compuestos de acido quinolin-2-il-benzoico.
CA2175420C (en) * 1995-05-17 2007-04-10 Gareth Griffiths Process for the preparation of optionally 2-substituted 5-chloroimidazole-4-carbaldehydes
JP4103149B2 (ja) * 1996-01-05 2008-06-18 ロンザ リミテッド 2−置換5−クロロイミダゾール−4−カルブアルデヒドの製造方法
JPH09202774A (ja) 1996-01-25 1997-08-05 Green Cross Corp:The 2−アリールキノリン類およびその製造方法
JP3890453B2 (ja) 1996-09-18 2007-03-07 リードケミカル株式会社 新規2,4−ジオキソピロリジンおよび2,4−ジオキソテトラヒドロフラン誘導体及び該化合物を有効成分とする医薬
IT1295405B1 (it) 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
BR9908474A (pt) 1998-03-04 2000-12-05 Takeda Chemical Industries Ltd Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents
WO2003093262A2 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
DE10335027A1 (de) 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2595962A1 (en) * 2005-02-03 2006-08-10 Ratiopharm Gmbh Method for the production of losartan
EP1871745B1 (en) * 2005-04-15 2010-10-20 Dishman Pharmaceuticals and Chemicals Ltd. Preparation of 2-substituted 4-chloro-5-formylimidazoles by vilsmeier reaction of the condensation product of glycine and an imido ester with a formamide in the presence of a triflate (trifluormethanesulphonate) catalyst
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20090299177A1 (en) * 2008-06-03 2009-12-03 Mallinckrodt Inc. Risk Stratification of Patients with Chronic Myocardial Infarction
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN102584628B (zh) * 2011-12-30 2015-04-22 浙江外国语学院 一种n-羧甲基戊脒的合成方法
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
US10905676B2 (en) 2017-07-07 2021-02-02 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH510394A (de) * 1969-07-04 1971-07-31 Ciba Geigy Ag Akarizides Mittel
CA1066709A (en) 1975-03-10 1979-11-20 Walter A.M. Helsen Preparation of loweralkyl imidazole carboxylates
JPS54148788A (en) * 1978-05-15 1979-11-21 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
JPS611022A (ja) * 1985-06-03 1986-01-07 Hitachi Ltd 半導体集積回路装置

Also Published As

Publication number Publication date
NO151966B (no) 1985-04-01
ATE5880T1 (de) 1984-02-15
SU999966A3 (ru) 1983-02-23
ES8204724A1 (es) 1982-05-01
NO151966C (no) 1985-07-10
HU185389B (en) 1985-01-28
NZ195517A (en) 1982-12-07
PT72049B (pt) 1981-09-24
NO803388L (no) 1981-05-13
EP0028834B1 (en) 1984-01-18
AU6412280A (en) 1981-05-21
DE3066205D1 (en) 1984-02-23
JPS6364428B2 (sv) 1988-12-12
IL61359A0 (en) 1980-12-31
JPS5671074A (en) 1981-06-13
EP0028834A1 (en) 1981-05-20
FI803508L (fi) 1981-05-13
PT72049A (en) 1980-12-01
US4355040A (en) 1982-10-19
DK478980A (da) 1981-05-13
GR72124B (sv) 1983-09-16
CA1152516A (en) 1983-08-23
ZA806832B (en) 1981-10-28
ES496709A0 (es) 1982-05-01

Similar Documents

Publication Publication Date Title
AR228957A1 (es) Procedimiento para obtener compuestos del acido 1-bencil-4-halo-imidazol-5-acetico y de sus sales y procedimiento para preparar composiciones farmaceuticas que incluyen a dichos compuestos del acido 1-bencil-4-haloimidazol-5-acetico,como agente activo
ES489887A0 (es) Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico.
AR230065A1 (es) Nuevas sales monoester del acido fosforico un procedimiento para su preparacion y composicion fungicidas que contienen dichos compuestos como ingrediente activo
MX158338A (es) Procedimiento para preparar derivados del acido 7-acilamino-3-vinilcefaslosporanico
MX5582E (es) Procedimiento para preparar derivados del acido 1,2,3-tiadiazola-5-carboxilico
AR226317A1 (es) Derivados del acido n-(3-fenoxibenzoil)-antranilico y composiciones herbicidas que los contienen como agente activo
AR226300A1 (es) Derivados del acido 4-(halo-2-quinolil o quinoxalil)-oxi)fenoxiacetico,procedimientos para producirlos y composicion herbicida que los contiene
AR216284A1 (es) Acidos bencilfenoxi-2-propionico mono o disustituido y derivados del mismo,utiles como herbicidas,procedimiento para prepararlos y composiciones que los contienen
AR217232A1 (es) Derivados de acido 1-(bis-trifluormetilfenil)-2-oxo-pirrolidin-4-carboxilico,un procedimiento para su obtencion y composiciones que los contienen como reguladores de crecimiento de plantas y herbicidas
AR222217A1 (es) Procedimiento para preparar una sustancia antibiotica seleccionada del grupo que consiste de la base libre de antibiotico a/16686 y sus sales de adicion de acido fisiologimente aceptables
MX4567E (es) Procedimiento para preparar acido de-n-propilacetico
AR218981A1 (es) Composiciones para la regulacion del crecimiento de las plantas en base a derivados de acidos cicloalcanocarboxilicos,como sustancia activa;nuevos derivados de acidos cicloalcanocarboxilicos para esas composiciones,y procedimiento para producir dichos derivados
AR202629A1 (es) Ester del acido ciclopropanocarboxilico, proceso para su preparacion y composiciones insecticidas que lo contienen
MX7169E (es) Procedimiento para preparar compuestos n-substituidos del acido diglicidil-isocianurico
ES487052A0 (es) Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico.
AR222304A1 (es) Procedimiento para preparar acido 4-isohexil-1-metilciclohexano-carboxilico
AR223518A1 (es) Esteres o-pirazolilicos del acido n,n-dimetil-carbamico,procedimiento para su produccion y composiciones plaguicidas que los contienen
AR220111A1 (es) Derivados de acido ftalamico y las sales agriculturalmente aceptables de los mismos,utiles como reguladores del crecimiento de plantas,y las composiciones reguladoras del crecimiento de plantas que los contienen
ES494479A0 (es) Procedimiento para preparar derivados del acido 7-amino-ce- falosporanico
AR226311A1 (es) Esteres o-pirimidinilicos del acido n,n-dimetilcarbamico,procedimientos para obtenerlos y composiciones plaguicidas que los contienen
AR223302A1 (es) Nuevos compuestos derivados de carbamatos de n-aminosulfenilo,particularmente utiles como agentes activos acaricidas,insecticidas selectivos,incluyendo afidicidas y nematocidas;procedimiento para la preparacion de estos nuevos compuestos y nuevas composiciones acaricidas,insecticidas selectivas,incluyendo afidicidas y nematocidas que incorporan a estos compuestos
AR220710A1 (es) Nuevos derivados de n-(2-oxoperhidro-3-furil)-anilidas del acido ciclopropanocarboxilico;composiciones fungicidas que contienen estos compuestos,y procedimientos para producirlos
IT978976B (it) Esteri o alchil s carbammoil ossimetilici dell acido tion tiolfosforico fosfonico procedi mento per la loro preparazione e loro impiego come insetticidi e come acaricidi
AR222640A1 (es) Un procedimiento para la preparacion de derivados del acido 9-0-alil-amino-alquilen-clavulanico,sales y esteres de bencilo,p-nitrobencilo y pivaloiloximetilo
MX4912E (es) Procedimiento para preparar derivados del acido 2-cianohexanoico